Vaccination with long NY-ESO-1 79-108 peptide and CpG-B leads to robust activation of CD4 and CD8 T cell responses in stage III/IV melanoma patients, and a new HLA-DR7 epitope

Detalles Bibliográficos
Autores principales: Baumgartner, Petra, Nunes, Carla Costa, Cachot, Amélie, Hajjami, Hélène Maby-El, Cagnon, Laurène, Braun, Marion, Derré, Laurent, Rivals, Jean-Paul, Rimoldi, Donata, Romano, Emanuela, Michielin, Olivier, Romero, Pedro, Jandus, Camilla, Speiser, Daniel E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652488/
http://dx.doi.org/10.1186/2051-1426-3-S2-P437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652488/
http://dx.doi.org/10.1186/2051-1426-3-S2-P437

Ejemplares similares